| 词条 | BioCompute Object |
| 释义 |
| title = BioCompute Object | long_name = | image = | caption = | status = [https://saaem-stg.ieee.org/project/2791.htm Active IEEE Working Group] | year_started = | first_published = | version = | version_date = | preview = | preview_date = | organization = | committee = | editors = | authors = | base_standards = | related_standards = Common Workflow Language | abbreviation = BCO | domain = | license = BSD-3-clause | website = {{URL|https://osf.io/h59uh/}} }} The BioCompute Object (BCO) Project is a community-driven initiative to build a framework for standardizing and sharing computations and analyses generated from High-throughput sequencing (HTS), also referred to as next-generation sequencing (NGS) or massively parallel sequencing (MPS).[1] Originally started as a collaborative contract between the George Washington University and the Food and Drug Administration, the project has grown to include over 20 universities, biotechnology companies, public-private partnerships and pharmaceutical companies including Seven Bridges and Harvard Medical School.[2] The BCO aims to ease the exchange of HTS workflows between various organizations, such as the FDA, pharmaceutical companies, contract research organizations, bioinformatic platform providers, and academic researchers. BackgroundOne of the biggest challenges in bioinformatics is documenting and sharing scientific workflows in a such a way that the computation and its results can be peer-reviewed or reliably reproduced.[3] Bioinformatic pipelines typically use multiple pieces of software, each of which typically has multiple versions available, multiple input parameters, multiple outputs, and possibly platform-specific configurations. As with experimental parameters in a laboratory protocol, small changes in computational parameters may have a large impact on the scientific validity of the results. The BioCompute Framework provides an object oriented design from which a BCO that contains details of a pipeline and how it was used can be constructed, digitally signed, and shared. The BioCompute concept was originally developed to satisfy FDA regulatory research and review needs for evaluation, validation, and verification of genomics data. However, the Biocompute Framework follows FAIR Data Principles[4] and can be used broadly to provide communication and interoperability between different platforms, industries, scientists and regulators[5] UtilityAs a standardization for genomic data, BioCompute Objects are mostly useful to three groups of users: 1) academic researchers carrying out new genetic experiments, 2) pharma/biotech companies that wish to submit work to the FDA for regulatory review, and 3) clinical settings (hospitals and labs) that offer genetic tests and personalized medicine. The utility to academic researchers is the ability to reproduce experimental data more accurately and with less uncertainty. The utility to entities wishing to submit work to the FDA is a streamlined approach, again with less uncertainty and with the ability to more accurately reproduce work. For clinical settings, it is critical that HTS data and clinical metadata be transmitted in an accurate way, ideally in a standardized way that is readable by any stakeholder, including regulatory partners. FormatThe BioCompute Object is in json format and, at a minimum, contains all the software versions and parameters necessary to evaluate or verify a computational pipeline. It may also contain input data as files or links, reference genomes, or executable Docker components. A BioCompute Object can be integrated with HL7 FHIR as a Provenance Resource[6] or Common Workflow Language as a Research Object.[7] BCO ConsortiumThe BioCompute Object working group facilitates a means for different stakeholders to provide input on current practices on the BCO. This working group was formed during preparation for the [https://hive.biochemistry.gwu.edu/htscsrs/workshop_2017 2017 HTS Computational Standards for Regulatory Sciences Workshop], and was initially made up of the workshop participants. There has been a continual growth of the BCO working group as a direct result of the interaction between a variety of stakeholders from all interested communities in standardization of computational HTS data processing. The Public-Private partnerships formed between universities, private genomic data companies, software platforms, government and regulatory institutions have been an easy point of entry for new individuals or institutions into the BCO project to participate in the discussion of best practices for the objects. References1. ^Simonyan V, Goecks J, Mazumder R. Biocompute Objects—A Step towards Evaluation and Validation of Biomedical Scientific Computations. PDA journal of pharmaceutical science and technology. 2017;71(2):136-146. doi:10.5731/pdajpst.2016.006734. 2. ^{{Cite web|url=https://www.europeanpharmaceuticalreview.com/news/67524/biocompute-genomic-data/|title=BioCompute Objects specifications to advance genomic data analysis|website=www.europeanpharmaceuticalreview.com|language=en|access-date=2017-12-21}} 3. ^{{cite journal|url=http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1003285|title=Ten Simple Rules for Reproducible Computational Research|first1=Geir Kjetil|last1=Sandve|first2=Anton|last2=Nekrutenko|first3=James|last3=Taylor|first4=Eivind|last4=Hovig|date=24 October 2013|publisher=|journal=PLOS Computational Biology|volume=9|issue=10|pages=e1003285|via=PLoS Journals|doi=10.1371/journal.pcbi.1003285}} 4. ^{{Cite journal|last=Wilkinson|first=Mark D.|last2=Dumontier|first2=Michel|last3=Aalbersberg|first3=IJsbrand Jan|last4=Appleton|first4=Gabrielle|last5=Axton|first5=Myles|last6=Baak|first6=Arie|last7=Blomberg|first7=Niklas|last8=Boiten|first8=Jan-Willem|last9=Santos|first9=Luiz Bonino da Silva|date=2016-03-15|title=The FAIR Guiding Principles for scientific data management and stewardship|url=https://www.nature.com/articles/sdata201618|journal=Scientific Data|language=En|volume=3|doi=10.1038/sdata.2016.18}} 5. ^{{cite journal|url=https://www.biorxiv.org/content/early/2017/09/21/191783|title=Enabling Precision Medicine via standard communication of NGS provenance, analysis, and results|first1=Gil|last1=Alterovitz|first2=Dennis A.|last2=Dean|first3=Carole|last3=Goble|first4=Michael R.|last4=Crusoe|first5=Stian|last5=Soiland-Reyes|first6=Amanda|last6=Bell|first7=Anais|last7=Hayes|first8=Charles Hadley H.|last8=King|first9=Elaine|last9=Johanson|first10=Elaine E.|last10=Thompson|first11=Eric|last11=Donaldson|first12=Hsinyi S.|last12=Tsang|first13=Jeremy|last13=Goecks|first14=Jonas S.|last14=Almeida|first15=Lydia|last15=Guo|first16=Mark|last16=Walderhaug|first17=Paul|last17=Walsh|first18=Robel|last18=Kahsay|first19=Toby|last19=Bloom|first20=Yuching|last20=Lai|first21=Vahan|last21=Simonyan|first22=Raja|last22=Mazumder|date=21 September 2017|publisher=|journal=bioRxiv|pages=191783|via=www.biorxiv.org|doi=10.1101/191783}} 6. ^{{Cite web|url=https://www.hl7.org/fhir/provenance-example-biocompute-object.html|title=Provenance-example-biocompute-object|last=|first=|date=|website=HL7 FHIR Release 3 (STU)|archive-url=|archive-date=|dead-url=|access-date=}} 7. ^{{Citation|last=Soiland-Reyes|first=Stian|title=hive-cwl-examples: Example BioCompute as Research Object with CWL|date=2016-12-19|url=https://github.com/stain/hive-cwl-examples|accessdate=2017-12-21}} External links
4 : Bioinformatics software|Interoperability|JSON|DNA sequencing |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。